首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1768081

胰臟癌治疗和诊断药物市场（按类型和地区）

Pancreatic Cancer Therapeutics and Diagnostic Market, By Type (Treatment (Targeted Therapies, Chemotherapy, Surgery, and Other Treatments)), By Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)

出版日期: 2025年06月09日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

胰臟癌治疗和诊断市场规模预计在 2025 年为 36.896 亿美元，预计到 2032 年将达到 60.393 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	36.896亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年	7.30%	2032年价值预测	60.393亿美元

胰臟癌是一种发生在胰臟细胞的癌症。当胰臟细胞发生变化（突变）导致其不受控制地生长时，就会发生胰臟癌。癌症可以透过超音波、电脑断层扫描 (CT)、磁振造影(MRI) 或正子断层扫描 (PET) 进行诊断。治疗可能包括手术、放射线治疗、化疗或多种疗法的组合。

市场动态

胰臟癌发病率和盛行率的上升、新型治疗方法的不断发展、老年人口的增加、对安全有效治疗的需求的增加以及人们意识的提高是预计将促进全球胰臟癌治疗和诊断市场成长的关键因素。

例如，2021年1月，Myriad Genetics Inc.和Illumina Inc.共同开发了基于套件的myChoice伴随诊断测试版本，用于检测胰腺癌，面向国际市场。

此外，2020年9月，印度医学研究理事会（ICMR）-国家癌症预防和研究中心（NICPR）推出了www.cancerindia.org，这是一个门户网站，提供有关印度主要癌症的信息，主要关注对癌症（包括胰腺癌）的认识、预防和治疗，主题为“印度抗击癌症”。

研究的主要特点

本报告对全球胰臟癌治疗和诊断市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率(CAGR)。
它强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
该报告涵盖了全球胰腺癌药物和诊断市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、关键亮点、绩效和策略。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
可以透过全球胰臟癌治疗和诊断市场分析中使用的各种策略矩阵来促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 3,689.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.30%	2032 Value Projection:	USD 6,039.3 Mn

Pancreatic cancer is cancer that forms in the cells of the pancreas. Pancreatic cancer occurs when changes (mutations) in the pancreas cells lead them to multiply out of control. The cancer can be diagnosed with the help of ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Treatment may include surgery, radiation, chemotherapy, or a combination of these.

Market Dynamics:

Rise in incidence and prevalence of pancreatic cancer, rise in development of novel therapeutics, growing geriatric population, increase in demand for safe and effective therapeutics, and increase in awareness among people are major factors expected to augment growth of the global pancreatic cancer therapeutics and diagnostic market.

For instance, in January 2021, Myriad Genetics Inc. and Illumina Inc. collaborated to develop a kit-based version of the myChoice companion diagnostic test for international markets, which can be used to detect pancreatic cancer.

Moreover, in September 2020, the Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR) launched www.cancerindia.org with the theme 'India against Cancer, a portal that provides information on the leading cancers in India with the major focus on awareness, prevention, and treatment of cancers, including pancreatic cancer.

Key features of the study:

This report provides in-depth analysis of the global pancreatic cancer therapeutics and diagnostic market, and provides market size (USD Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pancreatic cancer therapeutics and diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include F Hoffmann-La Roche AG, Merck KgaA, Apexigen Inc., Immunovia AB, Viatris Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb, Novartis AG, Pfizer Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, and Rafael Holdings Inc. (Rafael Pharmaceuticals), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global pancreatic cancer therapeutics and diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pancreatic cancer therapeutics and diagnostic market.

Detailed Segmentation:

Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type:
- Treatment
- Diagnostics
Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography:
- North America
- Europe
- Asia Pacific
- Middle East
- Africa
- Latin America
Company Profiles:
- F.Hoffmann-La Roche AG
- Merck KgaA
- Apexigen Inc.
- Immunovia AB
- Viatris Inc.
- Amgen Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb
- Novartis AG
- Pfizer Inc.
- Myriad Genetics Inc.
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Boston Scientific Corporation
- Rafael Holdings Inc. (Rafael Pharmaceuticals)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rise in incidence and prevalence of pancreatic cancer
- High cost associated with diagnosis and treatments
- Increase in demand for safe and effective therapeutics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

5. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - GCC Country
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
  - South Africa
  - North Africa
  - Central Africa

6. Competitive Landscape

F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Apexigen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Immunovia AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
FUJIFILM Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Rafael Holdings Inc. (Rafael Pharmaceuticals)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

7. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

胰臟癌治疗和诊断药物市场（按类型和地区）